Scarica l'app Stockscreener
8.28
0.60%
-0.05
Precedente Chiudi:
$8.33
Aprire:
$8.46
Volume 24 ore:
74,381
Relative Volume:
0.21
Capitalizzazione di mercato:
$268.53M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-12.57%
1M Prestazione:
-21.22%
6M Prestazione:
+0.00%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$7.90
$8.46
Intervallo di 1 settimana:
$7.90
$9.5693
Portata 52W:
$6.565
$13.47
Jade Biosciences Inc Stock (JBIO) Company Profile
Nome
Jade Biosciences Inc
Settore
Industria
Telefono
617-443-2400
Indirizzo
930 WINTER STREET, WALTHAM
Confronta JBIO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
JBIO
Jade Biosciences Inc
|
8.28 | 268.53M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Jade Biosciences Inc Stock (JBIO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-07-14 | Iniziato | Jefferies | Buy |
| 2025-06-16 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2025-05-07 | Iniziato | Wedbush | Outperform |
| 2025-05-05 | Iniziato | Stifel | Buy |
| 2025-05-02 | Iniziato | TD Cowen | Buy |
| 2024-06-18 | Downgrade | Evercore ISI | Outperform → In-line |
| 2024-06-18 | Downgrade | TD Cowen | Buy → Hold |
| 2024-06-18 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-06-17 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-06-17 | Downgrade | Guggenheim | Buy → Neutral |
| 2024-06-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2024-03-25 | Ripresa | Jefferies | Buy |
| 2023-12-08 | Iniziato | Wells Fargo | Equal Weight |
| 2023-03-01 | Iniziato | Guggenheim | Buy |
| 2022-12-06 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2022-09-19 | Ripresa | Wedbush | Outperform |
| 2022-08-16 | Downgrade | BTIG Research | Buy → Neutral |
| 2022-02-11 | Iniziato | BTIG Research | Buy |
| 2021-07-26 | Iniziato | Cowen | Outperform |
| 2021-07-26 | Iniziato | Evercore ISI | Outperform |
| 2021-07-26 | Iniziato | Jefferies | Buy |
| 2021-07-26 | Iniziato | Wedbush | Outperform |
Mostra tutto
Jade Biosciences Inc Borsa (JBIO) Ultime notizie
What makes Jade Biosciences Inc. stock price move sharplyRapid Gain Targets - Metal.it
Jade Biosciences Inc. Stock Analysis and ForecastRecord-setting profit potential - PrintWeekIndia
How high can Jade Biosciences Inc. stock price go in 2025Powerful growth strategies - jammulinksnews.com
What analysts say about Jade Biosciences Inc. stockAccelerated wealth expansion - Autocar Professional
Is Jade Biosciences Inc. a good long term investmentExplosive portfolio gains - PrintWeekIndia
What drives Jade Biosciences Inc. stock priceUnstoppable profit momentum - PrintWeekIndia
Why Jade Biosciences Inc. stock is on top investor watchlistsFree Predictions - jammulinksnews.com
IGM Biosciences Inc. Stock Analysis and ForecastLightning-fast growth - Autocar Professional
Jade Biosciences appoints Brad Dahms as CFO - MSN
Why Jade Biosciences Inc. stock attracts strong analyst attentionReal Time Stock Signal - Newser
How Jade Biosciences Inc. stock performs during market volatilityHigh Potential Safe Trades - Newser
Comparing Jade Art Group (OTCMKTS:JADA) and A-Mark Precious Metals (NASDAQ:AMRK) - Defense World
Jade Biosciences, Inc. to Participate in H.C. Wainwright and Stifel Biotech Investor Conferences - Nasdaq
Jade Biosciences to Participate in Two Upcoming Investor Conferences - GlobeNewswire
Jade Biosciences Inc Azioni (JBIO) Dati Finanziari
Non sono disponibili dati finanziari per Jade Biosciences Inc (JBIO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
0.22%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):